Metastatic Merkel Cell-Carcinoma and Myasthenia gravis: A Contraindication for Anti- PD-1 Antibody Therapy?

被引:0
|
作者
Hoge, J. [1 ]
Hagenacker, T. [2 ]
Chorti, E. [1 ]
Jockenhoefer, F. [1 ]
Zaremba, A. [1 ]
Ugurel, S. [1 ]
Schadendorf, D. [1 ]
Roesch, A. [1 ]
Livingstone, E. [1 ]
Zimmer, L. [1 ]
机构
[1] Univ Klinikum Essen, Dermatol Hauttumorzentrum, Essen, Germany
[2] Univ Klinikum Essen, Neurol, Essen, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P21
引用
收藏
页码:28 / 28
页数:1
相关论文
共 50 条
  • [1] Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
    Zaremba, Anne
    Chorti, Eleftheria
    Jockenhoefer, Finja
    Bolz, Saskia
    Sirin, Selma
    Glas, Martin
    Becker, Juergen C.
    Ugurel, Selma
    Boesch, Alexander
    Schadendorf, Dirk
    Livingstone, Elisabeth
    Hagenacker, Tim
    Zimmer, Lisa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [2] Therapy of the metastatic Merkel Cell Carcinoma with the Anti-PD-1 Antibody Pembrolizumab
    Meier, K.
    Wilhelmi, J.
    Lomberg, D.
    Spaenkuch, I
    Scheu, A.
    Leiter, U.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 171 - 171
  • [3] PD-1 Blockade as a therapeutic Option for metastatic Merkel Cell Carcinoma
    Winkler, J. K.
    Bender, C.
    Enk, A.
    Hassel, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 12 - 13
  • [4] PD-1 Blockade in an HIV Patient with Metastatic Merkel Cell Carcinoma
    Gellrich, F.
    Garzarolli, M.
    Blum, S.
    Beissert, S.
    Spornraft-Ragaller, P.
    Boashie, U.
    Meier, F.
    Rauschenberg, R.
    AKTUELLE DERMATOLOGIE, 2018, 44 (06) : 268 - 272
  • [5] Myasthenia gravis induced by pembrolizumab in a patient with metastatic Merkel cell carcinoma
    Pottier, C.
    El Habnouni, C.
    Kervarrec, T.
    Beltran, S.
    Samimi, M.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2022, 149 (02): : 142 - 145
  • [6] Myasthenia gravis-like Myopathy in metastatic cutaneous Squamous Cell Carcinoma under Anti-PD-1 Therapy
    Koett, J.
    Christolouka, M.
    Haalck, T.
    Schneider, S. W.
    Gebhardt, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 75 - 75
  • [7] Response to Anti-PD-1 Therapy in Metastatic Merkel Cell Carcinoma Metastatic to the Heart and Pancreas
    Mantripragada, Kalyan
    Birnbaum, Ariel
    CUREUS, 2015, 7 (12):
  • [8] Outcome of patient with myasthenia gravis with the use of immunotherapy in metastatic Merkel cell carcinoma
    Williams, Sarah
    Liang, Christina
    Guminski, Alexander
    Hruby, George
    Chan, David
    OXFORD MEDICAL CASE REPORTS, 2022, 2022 (02): : 67 - 70
  • [9] PD-1 blockade: a therapeutic option for treatment of metastatic Merkel cell carcinoma
    Winkler, J. K.
    Bender, C.
    Kratochwil, C.
    Enk, A.
    Hassel, J. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (01) : 216 - 219
  • [10] Treatment of metastatic urothelial cancer patients with myasthenia gravis with PD-1 inhibitors
    Ishii, A.
    Yokoyama, M.
    Tsuji, H.
    Fujii, Y.
    Tamaoka, A.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S57 - S57